P1096: TREATMENT OF HEPATITIS C-ASSOCIATED MARGINAL ZONE LYMPHOMA(HCV+LMZ) WITH DIRECT-ACTING ANTIVIRAL DRUGS (DAAS)
Main Authors: | Sergey Lepkov, Gayne Tumyan, Oleg Kolomeytsev, Svetlana Lunina, Anastasia Semenova, Natalia Kuprihina, Daria Tupicina, Natalia Kokosadze, Svetlana Borisovckay, Natalia Gavrilina, Kira Savkina, Roman Ivashenko, Olga Manuilova, Oleg Zaharov, Natalia Chernova, Maria Blagova, Efim Pozharskiy, Julia Ribukina, Vladimir Lazarev, Olga Ettinger, Igor Nikitin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971280.10111.0d |
Similar Items
-
PB2030: HYPERCHROMIC ANEMIA AS THE FIRST MANIFESTATION OF MYELOPROLIFERATIVE DISEASE
by: Sergey Lepkov, et al.
Published: (2023-08-01) -
PB1948: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME
by: Tatyana Byalik, et al.
Published: (2023-08-01) -
J.A. Coldeweij, De Heren van Kuyc 1096-1400
by: A.D.A. Monna
Published: (1985-01-01) -
P1096: TREATMENT PATTERNS AND OUTCOMES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
by: A. Bock, et al.
Published: (2022-06-01) -
Reply to Vrijdag et al. Comment on “Mankowska et al. Critical Flicker Fusion Frequency: A Narrative Review. <em>Medicina</em> 2021, <em>57</em>, 1096”
by: Natalia D. Mankowska, et al.
Published: (2022-06-01)